--------------------------------------------------------------------------------

EXHIBIT 10.21
 

AMENDMENT NO. 3 TO THE
GENENTECH, INC. SUPPLEMENTAL PLAN
(January 1, 2004 Restatement)
 
WHEREAS, the Genentech, Inc. Supplemental Plan (the “Plan”) was originally
established effective as of January 1, 1991 and was most recently amended and
restated in its entirety effective as of January 1, 2004, was amended effective
as of May 1, 2005 and further amended effective as of October 1, 2006;
 
WHEREAS, notwithstanding any provisions of the Plan to the contrary, Section
409A of the Internal Revenue Code of 1986, as amended (the “Code section 409A”)
requires that all non-qualified deferred compensation plans, like the Plan, be
in documentary compliance no later than December 31, 2008;
 
WHEREAS, Genentech, Inc. amended the Plan for Code section 409A compliance in
Amendment No. 1 to the Plan, effective as of May 1, 2005 (the “Amendment No.
1”);
 
WHEREAS, the Treasury Department has provided additional guidance regarding Code
section 409A, since the effectiveness of Amendment No.1, requiring an additional
amendment to the timing of the distribution to comply with Code section 409A.
 
NOW, THEREFORE, the Plan is hereby amended, effective as of December 18, 2008,
as follows:
 
FIRST:  Section 5.2 is amended in its entirety to read as follows:
 
“5.2           Time for Distribution.  The distribution of a Member’s Account
shall occur on the date that is six (6) months after the date of the Member’s
Separation From Service (as defined in Section 5.1) (the “Payment
Date”).  Notwithstanding any contrary Plan provision, any payment that is
scheduled to be made to a Member under the Plan on a Payment Date shall be made
no later than (a) the end of the Member’s taxable year that includes the Payment
Date, or (b) if later, the fifteenth (15th) day of the third calendar month
immediately following the Payment Date.  In no event, however, shall the Member
be permitted, directly or indirectly, to designate the taxable year of such
payment.”
 
IN WITNESS WHEREOF, Genentech, Inc., by its duly authorized officers, has
executed this Amendment No. 3 to the Plan on the date(s) indicated below.

 
 

--------------------------------------------------------------------------------

 
 

 
GENENTECH, INC.
 
By:
 /s/ Todd Rich
 
Title:
 V. P. Development RISQ
 
Dated:
 12/18/08
       
And by:
 /s/ William Anderson
 
Title:
 S.V.P. Sales + Marketing
 
Dated:
 12/18/08

                                     
 
 
-2-

--------------------------------------------------------------------------------